A study showed that glioblastoma-released sEVs expressing PD-L1 inhibited the activation and proliferation of CD4+ T and CD8+ T cells by binding to PD-1, leading to immune escape of glioblastoma cells (32). The gene discussed is CD8A; the disease is glioblastoma.